Discreet, evidence-based care for Massachusetts women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Massachusetts.
OmniRx Health providers are licensed by the Massachusetts Board of Registration in Medicine to deliver telehealth services across the Commonwealth.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Massachusetts passed comprehensive telehealth legislation requiring coverage parity, ensuring residents can access virtual care from licensed providers with confidence.
Massachusetts-licensed pharmacies in Boston, Worcester, Springfield, and across the Commonwealth partner with us for fast prescription fulfillment.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Massachusetts. If you choose cash-pay, no insurance EOB is sent to your household.